LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. - Abstract - Europe PMC
A pan-cancer assessment of alterations of the kinase domain of ULK1, an upstream regulator of autophagy | Scientific Reports
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. - Abstract - Europe PMC
Regulators of proteostasis are translationally repressed in fibroblasts from sporadic and LRRK2-G2019S Parkinson's patients | bioRxiv
Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides | ACS Chemical Biology
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. - Abstract - Europe PMC
Cocrystal structure of Roco4 kinase and LRRK2-IN-1. (A) Overlay of the... | Download Scientific Diagram
LRRK2 - Wikipedia
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway | Molecular Neurodegeneration | Full Text
Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1 | Communications Biology
ANIA: ANnotation and Integrated Analysis of the 14-3-3 interactome. - Abstract - Europe PMC
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models. - Abstract - Europe PMC
Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides | ACS Chemical Biology
Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1
LRRK2 Gene - GeneCards | LRRK2 Protein | LRRK2 Antibody
Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides | ACS Chemical Biology
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway | Molecular Neurodegeneration | Full Text
LRRK2 Gene - GeneCards | LRRK2 Protein | LRRK2 Antibody
anti-LRRK2 antibody (N-Term) | Product No. ABIN7044716
anti-LRRK2 antibody (N-Term) | Product No. ABIN7044716
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease - Abdelmoaty - 2022 - Clinical and Translational Medicine - Wiley Online Library
A pan-cancer assessment of alterations of the kinase domain of ULK1, an upstream regulator of autophagy | Scientific Reports
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. - Abstract - Europe PMC
